Kratom & Regulations
The opioid use epidemic remains a significant public health challenge in the United States. The DEA MATE Act requires clinicians to be knowledgeable in the prescribing and management of opioid use disorder (OUD), yet many treating teams continue to face challenges balancing chronic pain management, preventing opioid over‑prescription, and addressing illicit opioid use. This educational activity addresses gaps in recognizing OUD and withdrawal, applying person‑first language, and accessing evidence‑based treatments, including pharmacologic and psychotherapeutic approaches. Learners will also gain skills to identify barriers to medication access and appropriately refer patients for outpatient care, supporting the effective initiation and maintenance of OUD treatment.
Target Audience
Physicians and advanced-practice providers in psychiatry, emergency medicine, family medicine, internal medicine, and obstetrics and gynecology and the community.
Learning Objectives
At the conclusion of the session, the participants should be able to:
- Review the pharmacological profile of kratom, its active compounds, and its common formulations.
- Describe the mechanisms of action of kratom’s central components, including opioid receptor activity, and their implications for mental health and addiction.
- Discuss the potential benefits and challenges of regulating kratom as a scheduled substance.
Course summary
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Pain Management
- 0.50 Participation
- 0.50 Social Work
Social Work
Baylor College of Medicine, Division of Continuing Professional Development (License Number 7270) is an approved continuing education provider for Social Workers through the Texas State Board of Social Worker Examiners. This live activity has been approved for 0.50 continuing education units.
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Pain Management
- 0.50 Participation
- 0.50 Social Work

Facebook
X
LinkedIn
Forward